Who owns Antares Pharma?

Key details on Antares Pharma (Ticker: AIS)

Who owns Antares Pharma?

Is AIS a good stock to own? Find out who bought Antares Pharma, who sold Antares Pharma (AIS) stock, and who holds a large position in Antares Pharma.

Fund Name Number of Shares Share Valuation As Of
Deerfield Management Company 15.45M $26.27M Sept. 30, 2015
Broadfin Capital 8.47M $14.41M Sept. 30, 2015
ARMISTICE CAPITAL 8.30M $14.11M Sept. 30, 2015
Vanguard 5.25M $6.35M Dec. 31, 2015
BlackRock Institutional Trust Company, N.A. 4.13M $5.00M Dec. 31, 2015
BlackRock Fund Advisors 4.11M $4.97M Dec. 31, 2015
Millennium Management 3.44M $6.30M Sept. 30, 2014
OrbiMed Advisors 3.21M $11.25M March 31, 2014
Dr. Jeffrey R. Jay, M.D. 2.80M $5.82M June 30, 2015
Kingdon Capital Management 1.97M $3.34M Sept. 30, 2015
WEISS MULTI-STRATEGY ADVISERS 1.91M $4.21M Dec. 31, 2011
WEISS MULTI-STRATEGY ADVISERS 1.91M $4.21M Dec. 31, 2011
STATE STREET CORPORATION 1.91M $5.17M March 31, 2015
Allianz Asset Management AG 1.84M $6.42M March 31, 2014
NORTHERN TRUST 1.62M $2.76M Sept. 30, 2015
William Harris Investors 1.62M $1.96M Dec. 31, 2015
Renaissance Technologies 1.39M $1.68M Dec. 31, 2015

Who sold Antares Pharma?

Fund Name Date Sold Number of Shares Sold Share Valuation
VHCP Management Sept. 30, 2011 2.10M $4.87M